Why the study?
Does the apoB/apoA-I ratio improve the estimation of lipoprotein-related risk of fatal myocardial infarction compared to conventional cholesterol ratios in adults?
Does the apoB/apoA-I ratio improve the estimation of lipoprotein-related risk of fatal myocardial infarction compared to conventional cholesterol ratios in adults?
The apoB/apoA-I ratio is a more accurate index of lipoprotein-related risk of vascular disease than conventional cholesterol ratios, which frequently underestimate risk.
No takes yet. Share an insight, caveat, or question.
May support apoB/apoA-I for refined MI risk estimation; leaves open prospective validation before practice change.
Sniderman et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: